1 Introduction to Research & Analysis Reports
1.1 Anti-cancer Drug Exposure Evaluation Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-cancer Drug Exposure Evaluation Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-cancer Drug Exposure Evaluation Services Overall Market Size
2.1 Global Anti-cancer Drug Exposure Evaluation Services Market Size: 2022 VS 2029
2.2 Global Anti-cancer Drug Exposure Evaluation Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-cancer Drug Exposure Evaluation Services Players in Global Market
3.2 Top Global Anti-cancer Drug Exposure Evaluation Services Companies Ranked by Revenue
3.3 Global Anti-cancer Drug Exposure Evaluation Services Revenue by Companies
3.4 Top 3 and Top 5 Anti-cancer Drug Exposure Evaluation Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-cancer Drug Exposure Evaluation Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-cancer Drug Exposure Evaluation Services Players in Global Market
3.6.1 List of Global Tier 1 Anti-cancer Drug Exposure Evaluation Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-cancer Drug Exposure Evaluation Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Anti-cancer Drug Exposure Evaluation Services Market Size Markets, 2022 & 2029
4.1.2 Targeted Cancer Drugs
4.1.3 Immunotherapy Drugs
4.1.4 Other
4.2 By Type – Global Anti-cancer Drug Exposure Evaluation Services Revenue & Forecasts
4.2.1 By Type – Global Anti-cancer Drug Exposure Evaluation Services Revenue, 2018-2023
4.2.2 By Type – Global Anti-cancer Drug Exposure Evaluation Services Revenue, 2024-2029
4.2.3 By Type – Global Anti-cancer Drug Exposure Evaluation Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anti-cancer Drug Exposure Evaluation Services Market Size, 2022 & 2029
5.1.2 Pharmacy
5.1.3 Hospital
5.1.4 Out-Patient Chemotherapy Area
5.2 By Application – Global Anti-cancer Drug Exposure Evaluation Services Revenue & Forecasts
5.2.1 By Application – Global Anti-cancer Drug Exposure Evaluation Services Revenue, 2018-2023
5.2.2 By Application – Global Anti-cancer Drug Exposure Evaluation Services Revenue, 2024-2029
5.2.3 By Application – Global Anti-cancer Drug Exposure Evaluation Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Anti-cancer Drug Exposure Evaluation Services Market Size, 2022 & 2029
6.2 By Region – Global Anti-cancer Drug Exposure Evaluation Services Revenue & Forecasts
6.2.1 By Region – Global Anti-cancer Drug Exposure Evaluation Services Revenue, 2018-2023
6.2.2 By Region – Global Anti-cancer Drug Exposure Evaluation Services Revenue, 2024-2029
6.2.3 By Region – Global Anti-cancer Drug Exposure Evaluation Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Anti-cancer Drug Exposure Evaluation Services Revenue, 2018-2029
6.3.2 US Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.3.3 Canada Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.3.4 Mexico Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Anti-cancer Drug Exposure Evaluation Services Revenue, 2018-2029
6.4.2 Germany Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.4.3 France Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.4.4 U.K. Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.4.5 Italy Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.4.6 Russia Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.4.7 Nordic Countries Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.4.8 Benelux Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Anti-cancer Drug Exposure Evaluation Services Revenue, 2018-2029
6.5.2 China Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.5.3 Japan Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.5.4 South Korea Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.5.5 Southeast Asia Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.5.6 India Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Anti-cancer Drug Exposure Evaluation Services Revenue, 2018-2029
6.6.2 Brazil Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.6.3 Argentina Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Anti-cancer Drug Exposure Evaluation Services Revenue, 2018-2029
6.7.2 Turkey Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.7.3 Israel Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.7.4 Saudi Arabia Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
6.7.5 UAE Anti-cancer Drug Exposure Evaluation Services Market Size, 2018-2029
7 Anti-cancer Drug Exposure Evaluation Services Companies Profiles
7.1 IQVIA
7.1.1 IQVIA Company Summary
7.1.2 IQVIA Business Overview
7.1.3 IQVIA Anti-cancer Drug Exposure Evaluation Services Major Product Offerings
7.1.4 IQVIA Anti-cancer Drug Exposure Evaluation Services Revenue in Global Market (2018-2023)
7.1.5 IQVIA Key News & Latest Developments
7.2 Labcorp
7.2.1 Labcorp Company Summary
7.2.2 Labcorp Business Overview
7.2.3 Labcorp Anti-cancer Drug Exposure Evaluation Services Major Product Offerings
7.2.4 Labcorp Anti-cancer Drug Exposure Evaluation Services Revenue in Global Market (2018-2023)
7.2.5 Labcorp Key News & Latest Developments
7.3 PPD
7.3.1 PPD Company Summary
7.3.2 PPD Business Overview
7.3.3 PPD Anti-cancer Drug Exposure Evaluation Services Major Product Offerings
7.3.4 PPD Anti-cancer Drug Exposure Evaluation Services Revenue in Global Market (2018-2023)
7.3.5 PPD Key News & Latest Developments
7.4 ICON
7.4.1 ICON Company Summary
7.4.2 ICON Business Overview
7.4.3 ICON Anti-cancer Drug Exposure Evaluation Services Major Product Offerings
7.4.4 ICON Anti-cancer Drug Exposure Evaluation Services Revenue in Global Market (2018-2023)
7.4.5 ICON Key News & Latest Developments
7.5 Parexel
7.5.1 Parexel Company Summary
7.5.2 Parexel Business Overview
7.5.3 Parexel Anti-cancer Drug Exposure Evaluation Services Major Product Offerings
7.5.4 Parexel Anti-cancer Drug Exposure Evaluation Services Revenue in Global Market (2018-2023)
7.5.5 Parexel Key News & Latest Developments
7.6 Celerion
7.6.1 Celerion Company Summary
7.6.2 Celerion Business Overview
7.6.3 Celerion Anti-cancer Drug Exposure Evaluation Services Major Product Offerings
7.6.4 Celerion Anti-cancer Drug Exposure Evaluation Services Revenue in Global Market (2018-2023)
7.6.5 Celerion Key News & Latest Developments
7.7 Syneos Health
7.7.1 Syneos Health Company Summary
7.7.2 Syneos Health Business Overview
7.7.3 Syneos Health Anti-cancer Drug Exposure Evaluation Services Major Product Offerings
7.7.4 Syneos Health Anti-cancer Drug Exposure Evaluation Services Revenue in Global Market (2018-2023)
7.7.5 Syneos Health Key News & Latest Developments
7.8 WuXi AppTec
7.8.1 WuXi AppTec Company Summary
7.8.2 WuXi AppTec Business Overview
7.8.3 WuXi AppTec Anti-cancer Drug Exposure Evaluation Services Major Product Offerings
7.8.4 WuXi AppTec Anti-cancer Drug Exposure Evaluation Services Revenue in Global Market (2018-2023)
7.8.5 WuXi AppTec Key News & Latest Developments
7.9 Frontage Laboratories
7.9.1 Frontage Laboratories Company Summary
7.9.2 Frontage Laboratories Business Overview
7.9.3 Frontage Laboratories Anti-cancer Drug Exposure Evaluation Services Major Product Offerings
7.9.4 Frontage Laboratories Anti-cancer Drug Exposure Evaluation Services Revenue in Global Market (2018-2023)
7.9.5 Frontage Laboratories Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. Anti-cancer Drug Exposure Evaluation Services Market Opportunities & Trends in Global Market
Table 2. Anti-cancer Drug Exposure Evaluation Services Market Drivers in Global Market
Table 3. Anti-cancer Drug Exposure Evaluation Services Market Restraints in Global Market
Table 4. Key Players of Anti-cancer Drug Exposure Evaluation Services in Global Market
Table 5. Top Anti-cancer Drug Exposure Evaluation Services Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-cancer Drug Exposure Evaluation Services Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-cancer Drug Exposure Evaluation Services Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-cancer Drug Exposure Evaluation Services Product Type
Table 9. List of Global Tier 1 Anti-cancer Drug Exposure Evaluation Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-cancer Drug Exposure Evaluation Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anti-cancer Drug Exposure Evaluation Services Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-cancer Drug Exposure Evaluation Services Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anti-cancer Drug Exposure Evaluation Services Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-cancer Drug Exposure Evaluation Services Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anti-cancer Drug Exposure Evaluation Services Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-cancer Drug Exposure Evaluation Services Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2024-2029
Table 30. IQVIA Company Summary
Table 31. IQVIA Anti-cancer Drug Exposure Evaluation Services Product Offerings
Table 32. IQVIA Anti-cancer Drug Exposure Evaluation Services Revenue (US$, Mn) & (2018-2023)
Table 33. IQVIA Key News & Latest Developments
Table 34. Labcorp Company Summary
Table 35. Labcorp Anti-cancer Drug Exposure Evaluation Services Product Offerings
Table 36. Labcorp Anti-cancer Drug Exposure Evaluation Services Revenue (US$, Mn) & (2018-2023)
Table 37. Labcorp Key News & Latest Developments
Table 38. PPD Company Summary
Table 39. PPD Anti-cancer Drug Exposure Evaluation Services Product Offerings
Table 40. PPD Anti-cancer Drug Exposure Evaluation Services Revenue (US$, Mn) & (2018-2023)
Table 41. PPD Key News & Latest Developments
Table 42. ICON Company Summary
Table 43. ICON Anti-cancer Drug Exposure Evaluation Services Product Offerings
Table 44. ICON Anti-cancer Drug Exposure Evaluation Services Revenue (US$, Mn) & (2018-2023)
Table 45. ICON Key News & Latest Developments
Table 46. Parexel Company Summary
Table 47. Parexel Anti-cancer Drug Exposure Evaluation Services Product Offerings
Table 48. Parexel Anti-cancer Drug Exposure Evaluation Services Revenue (US$, Mn) & (2018-2023)
Table 49. Parexel Key News & Latest Developments
Table 50. Celerion Company Summary
Table 51. Celerion Anti-cancer Drug Exposure Evaluation Services Product Offerings
Table 52. Celerion Anti-cancer Drug Exposure Evaluation Services Revenue (US$, Mn) & (2018-2023)
Table 53. Celerion Key News & Latest Developments
Table 54. Syneos Health Company Summary
Table 55. Syneos Health Anti-cancer Drug Exposure Evaluation Services Product Offerings
Table 56. Syneos Health Anti-cancer Drug Exposure Evaluation Services Revenue (US$, Mn) & (2018-2023)
Table 57. Syneos Health Key News & Latest Developments
Table 58. WuXi AppTec Company Summary
Table 59. WuXi AppTec Anti-cancer Drug Exposure Evaluation Services Product Offerings
Table 60. WuXi AppTec Anti-cancer Drug Exposure Evaluation Services Revenue (US$, Mn) & (2018-2023)
Table 61. WuXi AppTec Key News & Latest Developments
Table 62. Frontage Laboratories Company Summary
Table 63. Frontage Laboratories Anti-cancer Drug Exposure Evaluation Services Product Offerings
Table 64. Frontage Laboratories Anti-cancer Drug Exposure Evaluation Services Revenue (US$, Mn) & (2018-2023)
Table 65. Frontage Laboratories Key News & Latest Developments
List of Figures
Figure 1. Anti-cancer Drug Exposure Evaluation Services Segment by Type in 2022
Figure 2. Anti-cancer Drug Exposure Evaluation Services Segment by Application in 2022
Figure 3. Global Anti-cancer Drug Exposure Evaluation Services Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-cancer Drug Exposure Evaluation Services Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-cancer Drug Exposure Evaluation Services Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-cancer Drug Exposure Evaluation Services Revenue in 2022
Figure 8. By Type - Global Anti-cancer Drug Exposure Evaluation Services Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anti-cancer Drug Exposure Evaluation Services Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anti-cancer Drug Exposure Evaluation Services Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anti-cancer Drug Exposure Evaluation Services Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anti-cancer Drug Exposure Evaluation Services Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anti-cancer Drug Exposure Evaluation Services Revenue Market Share, 2018-2029
Figure 16. US Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anti-cancer Drug Exposure Evaluation Services Revenue Market Share, 2018-2029
Figure 20. Germany Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 21. France Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anti-cancer Drug Exposure Evaluation Services Revenue Market Share, 2018-2029
Figure 28. China Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 32. India Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anti-cancer Drug Exposure Evaluation Services Revenue Market Share, 2018-2029
Figure 34. Brazil Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anti-cancer Drug Exposure Evaluation Services Revenue Market Share, 2018-2029
Figure 37. Turkey Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anti-cancer Drug Exposure Evaluation Services Revenue, (US$, Mn), 2018-2029
Figure 41. IQVIA Anti-cancer Drug Exposure Evaluation Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Labcorp Anti-cancer Drug Exposure Evaluation Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. PPD Anti-cancer Drug Exposure Evaluation Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. ICON Anti-cancer Drug Exposure Evaluation Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Parexel Anti-cancer Drug Exposure Evaluation Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Celerion Anti-cancer Drug Exposure Evaluation Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Syneos Health Anti-cancer Drug Exposure Evaluation Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. WuXi AppTec Anti-cancer Drug Exposure Evaluation Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Frontage Laboratories Anti-cancer Drug Exposure Evaluation Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
